Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.

Igor Novitzky-BassoCarol ChenShiyi ChenJeffrey Howard LiptonDennis D KimAuro ViswabandyaRajat KumarWilson LamArjun LawZeyad Al-ShaibaniArmin GerbitzIvan PasicJonas MattssonFotios V Michelis

Published in: European journal of haematology (2021)

Neither ELNr status nor pretransplant BMC influenced relapse post-HCT or OS. Hypocellularity and CRi are not negative prognostic factors for post-HCT outcomes of AML.

Keyphrases

prognostic factors
bone marrow
free survival
acute myeloid leukemia
stem cells
mesenchymal stem cells
stem cell transplantation
allogeneic hematopoietic stem cell transplantation
cell cycle arrest
type diabetes
cell death
cell proliferation